Quarterly report pursuant to Section 13 or 15(d)

Common Stock and Employee Equity Plans (Tables)

v3.23.2
Common Stock and Employee Equity Plans (Tables) - USD ($)
shares in Thousands, $ in Millions
 6 Months Ended
Jul. 01, 2023
Jun. 25, 2022
Equity [Abstract]    
Schedule of Common Shares Outstanding
Common Stock
Shares of common stock outstanding were as follows:
Three Months Ended Six Months Ended
July 1,
2023		 June 25,
2022		 July 1,
2023		 June 25,
2022
(In millions)
Balance, beginning of period 1,609  1,620  1,612  1,207 
Common stock issued in the acquisition of Xilinx —  —  —  429 
Common stock issued under employee equity plans 4  3  5  3 
Common stock repurchases for tax withholding on equity awards —  (1) (1) (1)
Issuance of common stock upon warrant exercise 1  —  1  — 
Repurchases of common stock —  (10) (3) (26)
Balance, end of period 1,614  1,612  1,614  1,612 
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based Compensation
Stock-based compensation expense recorded in the Condensed Consolidated Statements of Operations was as follows: 
Three Months Ended Six Months Ended
July 1,
2023		 June 25,
2022		 July 1,
2023		 June 25,
2022
(In millions)
Cost of sales $ 10  $ 8  $ 18  $ 12 
Research and development 247  180  461  293 
Marketing, general and administrative 91  104  178  186 
Total $ 348  $ 292  $ 657  $ 491 
 
Stock Repurchased During Period, Shares 3,000  
Payments for Repurchase of Common Stock $ 241 $ 2,835